|
Volumn 24, Issue 5 SUPPL. 15, 1997, Pages
|
Paclitaxel in platinum-resistant ovarian cancer patients
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
PACLITAXEL;
ADULT;
AGED;
ALOPECIA;
ANEMIA;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
MYALGIA;
NEUTROPENIA;
OVARY CANCER;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ADULT;
AGED;
AMBULATORY CARE;
ANEMIA;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ARGENTINA;
CA-125 ANTIGEN;
CISPLATIN;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MICROTUBULES;
MIDDLE AGED;
NAUSEA;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEUTROPENIA;
OVARIAN NEOPLASMS;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
PREMEDICATION;
REMISSION INDUCTION;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TUMOR MARKERS, BIOLOGICAL;
VOMITING;
|
EID: 0342349994
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (15)
|
References (15)
|